BioAtla BCAB
OTC BCAB
$1.35 -0.15 (-10.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioAtla (BCAB) Depreciation & Amortization (CF) (2020 - 2026)

Updated

BioAtla (BCAB) reported Depreciation & Amortization (CF) of $120,000 for Q1 2026, down 34.4% from $183,000 a year earlier but up 531.6% from the prior quarter.

Analysis

BioAtla (BCAB) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For FY2025, BioAtla posted Depreciation & Amortization (CF) of $373,000, down 59.7% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of -18.0% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $925,000 in FY2024 (-24.2%), $1.22 million in FY2023 (+1.8%), $1.2 million in FY2022 (-9.8%) and $1.33 million in FY2021 (+31.9%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $19,000 in Q4 2025 and a high of $380,000 in Q3 2021.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last nine quarters, with an average decline of 43.7% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2021 (growth of 52.1%); the low point was Q4 2025 (a decline of 91.7%).
  • Per Business Quant data, the three quarters before Q1 2026 came in at $19,000 (Q4 2025), $56,000 (Q3 2025) and $115,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 BioAtla 2.25 Mn 2.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 120,000.00
Dec 31, 2025 19,000.00
Sep 30, 2025 56,000.00
Jun 30, 2025 115,000.00
Mar 31, 2025 183,000.00
Dec 31, 2024 228,000.00
Sep 30, 2024 228,000.00
Jun 30, 2024 229,000.00
Mar 31, 2024 240,000.00
Dec 31, 2023 368,000.00
Sep 30, 2023 270,000.00
Jun 30, 2023 290,000.00
Mar 31, 2023 293,000.00
Dec 31, 2022 298,000.00
Sep 30, 2022 300,000.00
Jun 30, 2022 288,000.00
Mar 31, 2022 313,000.00
Dec 31, 2021 314,000.00
Sep 30, 2021 380,000.00
Jun 30, 2021 327,000.00
API Access

BioAtla Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BCAB&period=max&api_key=YOUR_API_KEY